These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 10049269)

  • 41. Molecular epidemiology of the integron-located VEB-1 extended-spectrum beta-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand.
    Girlich D; Poirel L; Leelaporn A; Karim A; Tribuddharat C; Fennewald M; Nordmann P
    J Clin Microbiol; 2001 Jan; 39(1):175-82. PubMed ID: 11136767
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy.
    Rice LB; Carias LL; Bonomo RA; Shlaes DM
    J Infect Dis; 1996 Jan; 173(1):151-8. PubMed ID: 8537652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cloning and sequencing of the gene encoding Toho-2, a class A beta-lactamase preferentially inhibited by tazobactam.
    Ma L; Ishii Y; Ishiguro M; Matsuzawa H; Yamaguchi K
    Antimicrob Agents Chemother; 1998 May; 42(5):1181-6. PubMed ID: 9593147
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel genetic structure associated with an extended-spectrum beta-lactamase blaVEB gene in a Providencia stuartii clinical isolate from Algeria.
    Aubert D; Naas T; Lartigue MF; Nordmann P
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3590-2. PubMed ID: 16048993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of beta-lactamases responsible for resistance to extended-spectrum cephalosporins in Escherichia coli and Salmonella enterica strains from food-producing animals in the United Kingdom.
    Liebana E; Gibbs M; Clouting C; Barker L; Clifton-Hadley FA; Pleydell E; Abdalhamid B; Hanson ND; Martin L; Poppe C; Davies RH
    Microb Drug Resist; 2004; 10(1):1-9. PubMed ID: 15140388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Identification of a plasmid-mediated AmpC beta-lactamase from clinical isolates of Escherichia coli and Klebsiella pneumoniae].
    Wang Y; Li ZH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Oct; 28(10):685-8. PubMed ID: 16255953
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Production of a plasmid mediated AmpC-like beta-lactamase by a Klebsiella pneumoniae septicaemia isolate.
    Pörnull KJ; Rodrigo G; Dornbusch K
    J Antimicrob Chemother; 1994 Dec; 34(6):943-54. PubMed ID: 7730237
    [TBL] [Abstract][Full Text] [Related]  

  • 49. BEL-1, a novel clavulanic acid-inhibited extended-spectrum beta-lactamase, and the class 1 integron In120 in Pseudomonas aeruginosa.
    Poirel L; Brinas L; Verlinde A; Ide L; Nordmann P
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3743-8. PubMed ID: 16127048
    [TBL] [Abstract][Full Text] [Related]  

  • 50. First characterization of a Providencia stuartii clinical isolate from a Tunisian intensive care unit coproducing VEB-1-a, OXA-2, qnrA6 and aac(6')-Ib-cr determinants.
    Mahrouki S; Chihi H; Bourouis A; Ben Moussa M; Belhadj O
    Braz J Infect Dis; 2014; 18(2):211-4. PubMed ID: 24378226
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TEM-71, a novel plasmid-encoded, extended-spectrum beta-lactamase produced by a clinical isolate of Klebsiella pneumoniae.
    Rasheed JK; Anderson GJ; Queenan AM; Biddle JW; Oliver A; Jacoby GA; Bush K; Tenover FC
    Antimicrob Agents Chemother; 2002 Jun; 46(6):2000-3. PubMed ID: 12019125
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia.
    Rasheed JK; Jay C; Metchock B; Berkowitz F; Weigel L; Crellin J; Steward C; Hill B; Medeiros AA; Tenover FC
    Antimicrob Agents Chemother; 1997 Mar; 41(3):647-53. PubMed ID: 9056008
    [TBL] [Abstract][Full Text] [Related]  

  • 53. OXA-15, an extended-spectrum variant of OXA-2 beta-lactamase, isolated from a Pseudomonas aeruginosa strain.
    Danel F; Hall LM; Gur D; Livermore DM
    Antimicrob Agents Chemother; 1997 Apr; 41(4):785-90. PubMed ID: 9087490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phenotypic and molecular characterization of a novel beta-lactamase carried by Klebsiella pneumoniae, CTX-M-72, derived from CTX-M-3.
    Cheng J; Wang Q; Chen Y; Ye Y; Li H; Li X; Li JB
    J Gen Appl Microbiol; 2009 Jun; 55(3):207-16. PubMed ID: 19590148
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An integron-associated beta-lactamase (IBC-2) from Pseudomonas aeruginosa is a variant of the extended-spectrum beta-lactamase IBC-1.
    Mavroidi A; Tzelepi E; Tsakris A; Miriagou V; Sofianou D; Tzouvelekis LS
    J Antimicrob Chemother; 2001 Nov; 48(5):627-30. PubMed ID: 11679551
    [TBL] [Abstract][Full Text] [Related]  

  • 56. OXA-46, a new class D beta-lactamase of narrow substrate specificity encoded by a blaVIM-1-containing integron from a Pseudomonas aeruginosa clinical isolate.
    Giuliani F; Docquier JD; Riccio ML; Pagani L; Rossolini GM
    Antimicrob Agents Chemother; 2005 May; 49(5):1973-80. PubMed ID: 15855521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transferable class C beta-lactamases in Escherichia coli strains isolated in Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC beta-lactamase.
    Gazouli M; Tzouvelekis LS; Vatopoulos AC; Tzelepi E
    J Antimicrob Chemother; 1998 Oct; 42(4):419-25. PubMed ID: 9818739
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic-biochemical analysis and distribution of the Ambler class A beta-lactamase CME-2, responsible for extended-spectrum cephalosporin resistance in Chryseobacterium (Flavobacterium) meningosepticum.
    Bellais S; Poirel L; Naas T; Girlich D; Nordmann P
    Antimicrob Agents Chemother; 2000 Jan; 44(1):1-9. PubMed ID: 10602714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp. in European septicaemia isolates.
    Pörnull KJ; Göransson E; Rytting AS; Dornbusch K
    J Antimicrob Chemother; 1993 Oct; 32(4):559-70. PubMed ID: 8288497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dissemination of transferable CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
    Jeong SH; Bae IK; Kwon SB; Lee JH; Song JS; Jung HI; Sung KH; Jang SJ; Lee SH
    J Appl Microbiol; 2005; 98(4):921-7. PubMed ID: 15752339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.